The predictive value of single nucleotide polymorhpisms in the vascular endothelial growth factor system in patients with metastatic colorectal cancer treated with bevacizumab plus chemotherapy as first-line treatment: Results of the phase III ACT trial NCT00598156 translational study

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

OriginalsprogEngelsk
Publikationsdato2011
StatusUdgivet - 2011
BegivenhedASCO Annual Meeting 2011 - Chicago, USA
Varighed: 3. jun. 20117. jun. 2011

Konference

KonferenceASCO Annual Meeting 2011
LandUSA
ByChicago
Periode03/06/201107/06/2011

Citationsformater